Literature DB >> 33237823

Increased chemokines levels in patients with chronic obstructive pulmonary disease: correlation with quantitative computed tomography metrics.

Wendong Hao1,2, Manxiang Li1, Yamei Pang1, Weiping Du3, Xiaoqi Huang4.   

Abstract

OBJECTIVE: We sought to explore the relationships between multiple chemokines with spirometry, inflammatory mediators and CT findings of emphysema, small airways disease and bronchial wall thickness.
METHODS: All patients with COPD (n = 65) and healthy control subjects (n = 23) underwent high-resolution CT, with image analysis determining the low attenuation area (LAA), ratio of mean lung attenuation on expiratory and inspiratory scans (E/I MLD) and bronchial wall thickness of inner perimeter of a 10-mm diameter airway (Pi10). At enrollment, subjects underwent pulmonary function studies, chemokines and inflammatory mediators measurements.
RESULTS: Multiple chemokines (CCL2, CCL3, CCL5, CX3CL1, CXCL8, CXCL9, CXCL10, CXCL11 and CXCL12) and inflammatory mediators (MMP-9, MMP-12, IL-18 and neutrophil count) were markedly increased in the serum of COPD patients compared with healthy controls. There were associations between small airway disease (E/I MLD) and CCL11, CXCL8, CXCL10, CXCL11, CXCL12 and CX3CL1. Especially CXCL8 and CX3CL1 are strongly associated with E/I MLD (r = 0.74, p < 0.001; r = 0.76, p < 0.001, respectively). CXCL8, CXCL12 and CX3CL1 were moderately positively correlated with emphysema (%LAA) (r = 0.49, p < 0.05; r = 0.51, p < 0.05; r = 0.54, p < 0.01, respectively). Bronchial wall thickness (Pi10)showed no significant differences between the COPD and healthy controls,,but there was an association between Pi10 and FEV1% in COPD patients (r=-0.420, p = 0.048). Our statistical results showed that there were not any associations between airway wall thickness (Pi10) and chemokines.
CONCLUSION: Pulmonary chemokines levels are closely associated with the extent of gas trapping, small airways disease and emphysema identified on high-resolution chest CT scan. ADVANCES IN KNOWLEDGE: This study combines quantitative CT analysis with multiplex chemokines and inflammatory mediators to identify a new role of pathological changes in COPD.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 33237823      PMCID: PMC7934302          DOI: 10.1259/bjr.20201030

Source DB:  PubMed          Journal:  Br J Radiol        ISSN: 0007-1285            Impact factor:   3.039


  33 in total

Review 1.  Regulation of hematopoiesis by the chemokine system.

Authors:  Ornella Bonavita; Valeria Mollica Poeta; Matteo Massara; Alberto Mantovani; Raffaella Bonecchi
Journal:  Cytokine       Date:  2018-09       Impact factor: 3.861

Review 2.  Present and future utility of computed tomography scanning in the assessment and management of COPD.

Authors:  Kristoffer Ostridge; Tom M A Wilkinson
Journal:  Eur Respir J       Date:  2016-05-26       Impact factor: 16.671

3.  Relationship between quantitative CT metrics and health status and BODE in chronic obstructive pulmonary disease.

Authors:  Carlos H Martinez; Ya-Hong Chen; Phillip M Westgate; Lyrica X Liu; Susan Murray; Jeffrey L Curtis; Barry J Make; Ella A Kazerooni; David A Lynch; Nathaniel Marchetti; George R Washko; Fernando J Martinez; Meilan K Han
Journal:  Thorax       Date:  2012-05       Impact factor: 9.139

4.  The value of blood cytokines and chemokines in assessing COPD.

Authors:  Eric Bradford; Sean Jacobson; Jason Varasteh; Alejandro P Comellas; Prescott Woodruff; Wanda O'Neal; Dawn L DeMeo; Xingnan Li; Victor Kim; Michael Cho; Peter J Castaldi; Craig Hersh; Edwin K Silverman; James D Crapo; Katerina Kechris; Russell P Bowler
Journal:  Respir Res       Date:  2017-10-24

5.  Differences in interleukin-8 and tumor necrosis factor-alpha in induced sputum from patients with chronic obstructive pulmonary disease or asthma.

Authors:  V M Keatings; P D Collins; D M Scott; P J Barnes
Journal:  Am J Respir Crit Care Med       Date:  1996-02       Impact factor: 21.405

6.  Blood MCP-1 levels are increased in chronic obstructive pulmonary disease patients with prevalent emphysema.

Authors:  Antonino Di Stefano; Teresa Coccini; Elisa Roda; Cinzia Signorini; Bruno Balbi; Giuseppe Brunetti; Piero Ceriana
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2018-05-24

7.  Economic Burden of Chronic Obstructive Pulmonary Disease (COPD): A Systematic Literature Review.

Authors:  Ike Iheanacho; Shiyuan Zhang; Denise King; Maria Rizzo; Afisi S Ismaila
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2020-02-26

8.  The presence and progression of emphysema in COPD as determined by CT scanning and biomarker expression: a prospective analysis from the ECLIPSE study.

Authors:  Harvey O Coxson; Asger Dirksen; Lisa D Edwards; Julie C Yates; Alvar Agusti; Per Bakke; Peter Ma Calverley; Bartolome Celli; Courtney Crim; Annelyse Duvoix; Paola Nasute Fauerbach; David A Lomas; William Macnee; Ruth J Mayer; Bruce E Miller; Nestor L Müller; Stephen I Rennard; Edwin K Silverman; Ruth Tal-Singer; Emiel Fm Wouters; Jørgen Vestbo
Journal:  Lancet Respir Med       Date:  2013-02-01       Impact factor: 30.700

9.  Relationship between CT air trapping criteria and lung function in small airway impairment quantification.

Authors:  Sébastien Bommart; Grégory Marin; Arnaud Bourdin; Nicolas Molinari; François Klein; Maurice Hayot; Isabelle Vachier; Pascal Chanez; Jacques Mercier; Hélène Vernhet-Kovacsik
Journal:  BMC Pulm Med       Date:  2014-02-28       Impact factor: 3.317

View more
  2 in total

1.  N-Acetylcysteine (NAC) Inhibits Synthesis of IL-18 in Macrophage by Suppressing NLRP3 Expression to Reduce the Production of IFN-γ from NK Cells.

Authors:  Xiaopeng Liu; Xufeng Lu; Zhixiong Hu
Journal:  Comput Math Methods Med       Date:  2021-12-03       Impact factor: 2.238

2.  Identification of Hub Genes Associated with COPD Through Integrated Bioinformatics Analysis.

Authors:  Lin Chen; Donglan Zhu; Jinfu Huang; Hui Zhang; Guang Zhou; Xiaoning Zhong
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2022-03-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.